Both in Pharmaceuticals
Savara vs Jade Biosciences
Over the past year SVRA returned +7.7% and JBIO returned +56.0%; their daily moves had a correlation of 0.35.
SVRA +7.7% JBIO +56.0%Growth of $1, one year, split-adjusted
| Metric | SVRA | JBIO |
|---|---|---|
| Price | $4.60 | $14.77 |
| Market cap | $945.2M | $939.3M |
| Today | −3.15% | +1.37% |
| 1 month | −1.1% | +10.1% |
| 6 months | −12.7% | −41.2% |
| Year to date | −23.7% | −4.3% |
| 1 year | +7.7% | +56.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $142.9M | $461.2M |
| Dividend yield | — | — |
| Volatility (60d) | 48.6% | 52.2% |
| Short % of float | 20.1% | 20.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).